SCHEMBL7180177

SCHEMBL7180177

CCCCCC(=O)NS(=O)(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.54
FAAH O00519 6/20 0.52
EPHX2 P34913 1/20 0.50
MEN1 O00255 1/20 0.48
MAPK1 P28482 1/20 0.48
KMT2A Q03164 1/20 0.48
CES2 O00748 4/20 0.46
CES1 P23141 4/20 0.46
CASP2 P42575 1/20 0.45
AKR1B1 P15121 1/20 0.44
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
GPR84 Q9NQS5 2/20 0.43
PPARG P37231 2/20 0.43
PPARD Q03181 2/20 0.43
PPARA Q07869 2/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21060856 0.98 HSP90AA1 (0.57) HSP90AA1FAAHEPHX2MEN1MAPK1
SCHEMBL11649466 0.98 HSP90AA1 (0.57) HSP90AA1FAAHEPHX2MEN1MAPK1
SCHEMBL7184916 0.98 HSP90AA1 (0.57) HSP90AA1FAAHEPHX2MEN1MAPK1
SCHEMBL28194397 0.98 HSP90AA1 (0.52) HSP90AA1FAAHEPHX2MEN1MAPK1
SCHEMBL7185340 0.98 HSP90AA1 (0.57) HSP90AA1FAAHEPHX2MEN1MAPK1
SCHEMBL3477319 0.93 FNTA (0.46) HSP90AA1FAAHEPHX2MEN1MAPK1
SCHEMBL177558 0.84 HDAC3 (0.50) EPHX2MEN1KMT2ACES2CES1
SCHEMBL2810388 0.83 EPHX2 (0.62) HSP90AA1FAAHEPHX2MEN1MAPK1
SCHEMBL2807682 0.83 HSP90AA1 (0.54) HSP90AA1FAAHEPHX2MEN1MAPK1
Dodecanoate SCHEMBL29129545 0.82 FABP3 (0.51) HSP90AA1EPHX2CES2CES1CASP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101830497-B Supergravity hydrothermal preparation method of spherical inorganic powder grains UNIV TONGJI 2012-06-06 CN claimed
CN-102356066-A Novel 2,6-substituted-3-nitropyridine derivative, method for preparing same, and pharmaceutical composition including same DONG WHA PHARM CO LTD 2012-02-15 CN claimed
CN-101830497-A Supergravity hydrothermal preparation method of spherical inorganic powder grains UNIV TONGJI 2010-09-15 CN claimed
CN-101801967-A Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same DONG WHA PHARM IND CO LTD 2010-08-11 CN claimed
CN-101379049-A Novel benzamidine derivatives, process for preparing the same, and pharmaceutical composition comprising the same DONG WHA PHARM IND CO LTD (KR) 2009-03-04 CN claimed
CN-101010308-A Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same DONG WHA PHARM IND CO LTD (KR) 2007-08-01 CN claimed
US-6583130-B1 Substituted with acyl, oxycarbonyl, aminocarbonyl, sulfonyl, or aminosulfonyl; inhibit steroid sulfatase, do not exhibit any estrogenic effect and will not yield any estrogenic products on hydrolysis; treatment of estrogen-dependent tumors SCHERING AG (DE) 2003-06-24 US claimed
CN-109988151-A A kind of acetylene compound, preparation method and applications 北京赛特明强医药科技有限公司 2019-07-09 CN disclosed
CN-101830497-B Supergravity hydrothermal preparation method of spherical inorganic powder grains UNIV TONGJI 2012-06-06 CN disclosed
CN-102356066-A Novel 2,6-substituted-3-nitropyridine derivative, method for preparing same, and pharmaceutical composition including same DONG WHA PHARM CO LTD 2012-02-15 CN disclosed
CN-101379049-B Novel benzamidine derivatives, process for preparing the same, and pharmaceutical composition comprising the same DONG WHA PHARM IND CO LTD 2012-01-04 CN disclosed
CN-101830497-A Supergravity hydrothermal preparation method of spherical inorganic powder grains UNIV TONGJI 2010-09-15 CN disclosed
CN-101801967-A Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same DONG WHA PHARM IND CO LTD 2010-08-11 CN disclosed
CN-101379049-A Novel benzamidine derivatives, process for preparing the same, and pharmaceutical composition comprising the same DONG WHA PHARM IND CO LTD (KR) 2009-03-04 CN disclosed
CN-101010308-A Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same DONG WHA PHARM IND CO LTD (KR) 2007-08-01 CN disclosed
US-6583130-B1 Substituted with acyl, oxycarbonyl, aminocarbonyl, sulfonyl, or aminosulfonyl; inhibit steroid sulfatase, do not exhibit any estrogenic effect and will not yield any estrogenic products on hydrolysis; treatment of estrogen-dependent tumors SCHERING AG (DE) 2003-06-24 US disclosed